Guangzhou Darui Biotechnology Co., Ltd. engages in the research and development, and application of prenatal and postnatal care, and precision medical products. Its products and instruments are used in prenatal screening, screening of newborns, cancer screening and individualized drug guide, detection of infectious diseases, and sex hormone test. Its technology platform includes high-throughput sequencing, gene chip, flight mass spectrometry, chemiluminescent, time-resolved, and tandem mass spectrometry platform. The company was founded on August 11, 2003 and is headquartered in Guangzhou, China.